epalrestat: Clinical Trials

2 trials of epalrestat, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting, 1 terminated. 2 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 32Recruiting 1, Terminated 1
Phase 21Recruiting 1

Follow epalrestat: new trials by email Literature Review of epalrestat trials Research Report on epalrestat

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Evaluating a Nitric Oxide Generator, Nebivolol as a Disease Modifier in Patients With Diabetic Neuropathy.
Nebivolol+ Standard care arm, Epalrestat + Alpha Lipoic Acid +Standard care, Standard care alone - Diabetic Neuropathy Peripheral
Phase 2 / Phase 3RecruitingSt. John's Research Institute1202024-11-152025-02-04
Oral Epalrestat Therapy in Pediatric Subjects With PMM2-CDG
Epalrestat, Placebo - Pmm2-CDG, Phosphomannomutase 2 Deficiency
Phase 3TerminatedMaggie's Pearl, LLC422022-11-102025-09-25

Conditions studied

Congenital disorder of glycosylation type 1A (1)

Sponsors

Maggie's Pearl, LLC (1)  ·  St. John's Research Institute (1)

Countries

India (1)  ·  United States (1)

Top investigators

Eva Morava-Kozicz, MD, PhD (1)